Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects

European Journal of Endocrinology

Volumn 163, Issue 1, 2010, Pages 75-80

  Succurro, Elena ^a   Arturi, Franco ^a   Grembiale, Alessandro ^a   Iorio, Fiorella ^a   Laino, Irma ^a   Andreozzi, Francesco ^a   Sciacqua, Angela ^a   Hribal, Marta Letizia ^a   Perticone, Francesco ^a   Sesti, Giorgio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; AGED; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; YOUNG ADULT;

EID: 77954124200     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0113     Document Type: Article

References (30)

1. Colao A, Spiezia S, Di Somma C, Pivonello R, Marzullo P, Rota F, Musella T, Auriemma RS, De Martino MC & Lombardi G. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. Journal of Endocrinological Investigation 2005 28 440-448. (Pubitemid 43162741)
2. Spallarossa P, Brunelli C, Minuto F, Caruso D, Battistini M, Caponnetto S & Cordera R. Insulin-like growth factor-I and angiographically documented coronary artery disease. American Journal of Cardiology 1996 77 200-202. (Pubitemid 26032614)
3. Conti E, Andreotti F, Sciahbasi A, Riccardi P, Marra G, Menini E, Ghirlanda G & Maseri A. Markedly reduced insulin-like growth factor-I in the acute phase of myocardial infarction. Journal of the American College of Cardiology 2001 38 26-32. (Pubitemid 32613824)
4. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case - control study. Circulation 2002 106 939-944. (Pubitemid 34925327)
5. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120. (Pubitemid 38183869)
6. Kaplan RC, McGinn AP, Pollak MN, Kuller LH, Strickler HD, Rohan TE, Cappola AR, Xue XN & Psaty BM. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke. Journal of Clinical Endocrinology and Metabolism 2007 92 1319-1325.
7. Ruotolo G, Båvenholm P, Brismar K, Eféndic S, Ericsson CG, de Faire U, Nilsson J & Hamsten A. Serum insulin-like growth factor-I level is independently associated with coronary artery disease progression in young male survivors of myocardial infarction: beneficial effects of bezafibrate treatment. Journal of the American College of Cardiology 2000 35 647-654. (Pubitemid 30167021)
8. Fischer F, Schulte H, Mohan S, Tataru MC, Köhler E, Assmann G & von Eckardstein A. Associations of insulin-like growth factors, insulin-like growth factor binding proteins and acid-labile subunit with coronary heart disease. Clinical Endocrinology 2004 61 595-602. (Pubitemid 39540361)
9. Schneider HJ, Klotsche J, Saller B, Böhler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher AM, Silber S, Lehnert H, Wittchen HU & Stalla GK. Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: crosssectional study in 6773 primary care patients. European Journal of Endocrinology 2008 158 153-161. (Pubitemid 351298531)
10. Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, Perticone F & Sesti G. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy non-obese women and obese insulin resistant women. Diabetes Care 2007 30 2145-2147. (Pubitemid 47219439)
11. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745.
12. Sesti G, Sciacqua A, Cardellini M, Marini MA, Maio R, Vatrano M, Succurro E, Lauro R, Federici M & Perticone F. Plasma concentration of insulin-like growth factor-I is independently associated with insulin sensitivity in subjects with different degree of glucose tolerance. Diabetes Care 2005 28 132-137.
13. Succurro E, Andreozzi F, Marini MA, Lauro R, Hribal ML, Perticone F & Sesti G. Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. Nutrition, Metabolism, and Cardiovascular Diseases 2009 19 713-719.
14. Perticone F, Sciacqua A, Perticone M, Laino I, Miceli S, Care' I, Galiano Leone G, Andreozzi F, Maio R & Sesti G. Low plasma insulin-like growth factor-1 levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated hypertensive Caucasian subjects. Journal of Clinical Endocrinology and Metabolism 2008 93 2806-2810.
15. Sesti G, Sciacqua A, Scozzafava A, Vatrano M, Angotti E, Ruberto C, Santillo E, Parlato G & Perticone F. Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients. Journal of Hypertension 2007 25 471-477. (Pubitemid 46071947)
16. Succurro E, Andreozzi F, Sciaqua A, Hribal ML, Perticone F & Sesti G. Reciprocal association of plasma insulin-like growth factor-1 and interleukin-6 levels with cardio-metabolic risk factors in nondiabetic subjects. Diabetes Care 2008 31 1886-1888.
17. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S & Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989 79 8-15.
18. Norata GD, Pirillo A & Catapano AL. Modified HDL: biological and physiopathological consequences. Nutrition, Metabolism, and Cardiovascular Diseases 2006 16 371-386.
19. Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC & Treating to New Targets Investigators . HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. New England Journal of Medicine 2007 357 1301-1310.
20. Ceda GP, Dall'Aglio E, Magnacavallo A, Vargas N, Fontana V, Maggio M, Valenti G, Lee PD, Hintz RL & Hoffman AR. The insulin-like growth factor axis and plasma lipid levels in the elderly. Journal of Clinical Endocrinology and Metabolism 1998 83 499-502. (Pubitemid 28496529)
21. Nelson SM, Freeman DJ, Sattar N, Johnstone FD & Lindsay RS. IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes 2007 56 2705-2709.
22. Götherström G, Bengtsson BA, Bosaeus I, Johannsson G & Svensson J. A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. Journal of Clinical Endocrinology and Metabolism 2007 92 1442-1445. (Pubitemid 46562361)
23. Moses AC, Young SC, Morrow LA, O'Brien M & Clemmons DR. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996 45 91-100. (Pubitemid 26010429)
24. Federici M, Porzio O, Lauro D, Borboni P, Giovannone B, Zucaro L, Hribal ML & Sesti G. Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 1998 83 2911-2915. (Pubitemid 28493797)
25. Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia 2003 46 733-749. (Pubitemid 36831401)
26. Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, Frontoni S, Leonetti F, Luzi L, Marchesini G, Marini MA, Natali A, Paolisso G, Piatti PM, Pujia A, Solini A, Vettor R, Bonadonna RC & Group of Italian Scientists of Insulin Resistance (GISIR). Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutrition, Metabolism, and Cardiovascular Diseases 2008 18 624-631.
27. Timmins JM, Lee JY, Boudyguina E, Kluckman KD, Brunham LR, Mulya A, Gebre AK, Coutinho JM, Colvin PL, Smith TL, Hayden MR, Maeda N & Parks JS. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. Journal of Clinical Investigation 2005 115 1333-1342. (Pubitemid 40629053)
28. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH & Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996 271 518-520. (Pubitemid 26044473)
29. Cao WM, Murao K, Imachi H, Yu X, Dobashi H, Yoshida K, Muraoka T, Kotsuna N, Nagao S,Wong NC & Ishida T. Insulin-like growth factor-1 regulation of hepatic scavenger receptor class BI. Endocrinology 2004 145 5540-5547. (Pubitemid 39564594)
30. Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE & Riboli E. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. Journal of the National Cancer Institute 2000 92 1592-1600.